Population Triage during a Nuclear Incident (IMAGE)
Caption
The need to rapidly screen a population for possible radiation exposure in the event of a nuclear incident has led to a multi-year, multi-million government, academic and industry collaboration. These efforts combine ASU's development of radiation biomarkers, automation and software for estimating an individual's absorbed dose with Thermo Fisher's expertise in the product commercialization process," said Joshua LaBaer, who also serves as director of the Biodesign Institute's Virginia G. Piper Center for Personalized Diagnostics. 'Our research team's ultimate goal is to translate our discoveries into an automated high-throughput diagnostic system for radiation biodosimetry that is capable of processing a high volume of blood samples per day.'
Credit
Biodesign Institute, Arizona State University
Usage Restrictions
None
License
Licensed content